2002
DOI: 10.1016/s0306-4522(02)00249-x
|View full text |Cite
|
Sign up to set email alerts
|

Ultrastructural localization of enkephalin and μ-opioid receptors in the rat ventral tegmental area

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 111 publications
2
16
1
Order By: Relevance
“…As mentioned previously, our results indicate that endogenous enkephalins play an important role in mediating the rewarding properties of nicotine. Enkephalinergic interneurons as well as enkephalinergic inputs from the NAc are present in the VTA (Garzó n and Pickel, 2002). Therefore, we suggest that nicotine could induce, by a direct mechanism or indirectly through glutamate transmission (Isola et al, 2000), a release of endogenous opioid peptides derived from preproenkephalin.…”
Section: Discussionmentioning
confidence: 84%
“…As mentioned previously, our results indicate that endogenous enkephalins play an important role in mediating the rewarding properties of nicotine. Enkephalinergic interneurons as well as enkephalinergic inputs from the NAc are present in the VTA (Garzó n and Pickel, 2002). Therefore, we suggest that nicotine could induce, by a direct mechanism or indirectly through glutamate transmission (Isola et al, 2000), a release of endogenous opioid peptides derived from preproenkephalin.…”
Section: Discussionmentioning
confidence: 84%
“…This upregulation of MORs is essential, since genetic MOR knockout mice do not exhibit social defeat stress-induced social avoidance (Komatsu et al, 2011), and MOR knockdown in rat VTA prevents cross-sensitization to amphetamine (Johnston et al, 2011). In the VTA, MORs are expressed by GABA neurons (Sesack and Pickel, 1995; Garzon and Pickel, 2002), which are hyperpolarized in response to MOR stimulation, and act to disinhibit VTA dopamine transmission (Johnson and North, 1992; Bergevin et al, 2002; Vargas-Perez et al, 2009). In fact, enhancement of VTA MOR expression (Nikulina et al, 2005; Nikulina et al, 2008) coincides with social defeat stress-induced cross-sensitization to psychomotor stimulants (Covington and Miczek, 2001; Nikulina et al, 2004; Nikulina et al, 2012), suggesting that GABAergic MORs in the VTA may mediate stress-induced psychomotor sensitization (Figure 2).…”
Section: Vta Bdnf and Stress-induced Vulnerability To Drugs Of Abusementioning
confidence: 99%
“…By contrast, knockdown of VTA MORs prevented social stress-induced cross-sensitization without blocking amphetamine-induced locomotion. VTA MORs are presynaptically expressed by GABA neurons (Garzon and Pickel, 2002; Sesack and Pickel, 1995), and when activated, reduce GABAergic inhibition of VTA DA neurons (Bergevin et al, 2002; Dacher and Nugent, 2011; Johnson and North, 1992; Trigo et al, 2010; Vargas-Perez et al, 2009) and facilitate response to psychomotor stimulants. Thus, if stimulation of MORs in the VTA indirectly increases VTA DA activity by reducing GABA transmission, then it is likely that knockdown of VTA MORs increases GABA release.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, even acute social defeat stress has been shown to rapidly upregulate MOR mRNA expression in the ventral tegmental area (VTA; Nikulina et al, 1999), while repeated social stress exposure increases VTA MOR mRNA expression for up to 14 days after the last episode (Nikulina et al, 2008). In the VTA MORs are expressed by gamma-aminobutyric acid (GABA) neurons (Garzon and Pickel, 2002; Sesack and Pickel, 1995), which are hyperpolarized in response to MOR stimulation, thus disinhibiting local dopamine (DA) transmission and facilitating response to drugs of abuse (Bergevin et al, 2002; Dacher and Nugent, 2011; Johnson and North, 1992; Vargas-Perez et al, 2009). Rats exposed to repeated social defeat stress, then challenged with an intra-VTA infusion of a MOR-specific agonist exhibited sensitized locomotor activity (Nikulina et al, 2008; Nikulina et al, 2005).…”
Section: Introductionmentioning
confidence: 99%